Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients
Ashraf Z. Badros, Olga Goloubeva, Aaron P. Rapoport, Bashi Ratterree, Natalie Gahres, Barry Meisenberg, Naoko Takebe, Meyer Heyman, James Zwiebel, Howard Streicher, Christopher D. Gocke, Dragana Tomic, Jodi A. Flaws, Bin Zhang, Robert G. Fenton
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Phase II study of G3139, a Bcl-2 antisense oligonucleotide, in combination with dexamethasone and thalidomide in relapsed multiple myeloma patients'. Together they form a unique fingerprint.